Dongcheng Pharmaceutical announced that the company recently received GMP certificates for 4 types of APIs from the Hamburg Health Authority, heparin sodium, natroparin calcium, and chondroitin sulfate. They are all valid for three years from the date of passing the inspection, indicating that the above products can continue to be sold in the EU market.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.